Phathom Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 10.11 M | $182.78 M | 0.00% | 15.64% |
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 10/15/2024 | 7.46 M | $134.96 M | 0.00% | 11.55% |
| JENNISON ASSOCIATES LLC | 11/08/2024 | 5.87 M | $106.06 M | 112.74% | 9.08% |
| INVESCO LTD. | 11/12/2024 | 4.10 M | $74.07 M | 30.33% | 6.34% |
| CARLYLE GROUP INC. | 11/08/2024 | 3.50 M | $63.19 M | 0.00% | 5.41% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3.12 M | $56.46 M | 100.00% | 4.83% |
| VANGUARD GROUP INC | 11/13/2024 | 2.70 M | $48.75 M | 21.91% | 4.17% |
| ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 2.58 M | $46.67 M | 14.99% | 3.99% |
| WOODLINE PARTNERS LP | 11/14/2024 | 2.57 M | $46.53 M | 227.41% | 3.98% |
| NEA MANAGEMENT COMPANY, LLC | 11/14/2024 | 1.96 M | $35.44 M | 0.00% | 3.03% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 1.80 M | $32.63 M | 11.39% | 2.79% |
| PORTOLAN CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.70 M | $30.73 M | 50.42% | 2.63% |
| GILDER GAGNON HOWE & CO LLC | 11/14/2024 | 1.62 M | $29.34 M | 10.23% | 2.51% |
| CHECKPOINT CAPITAL L.P. | 11/14/2024 | 1.50 M | $27.20 M | 71.92% | 2.33% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 1.45 M | $26.20 M | 100.00% | 2.24% |
| FMR LLC | 11/13/2024 | 1.30 M | $23.58 M | 49,000.68% | 2.02% |
| DECHENG CAPITAL LLC | 11/15/2024 | 1.25 M | $22.60 M | 47.06% | 1.93% |
| GW&K INVESTMENT MANAGEMENT, LLC | 11/07/2024 | 1.13 M | $20.36 M | 87.54% | 1.74% |
| CATALYS PACIFIC, LLC | 11/12/2024 | 1.12 M | $20.30 M | 55.49% | 1.74% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.01 M | $18.26 M | -27.86% | 1.56% |
| STATE STREET CORP | 11/14/2024 | 922,788 | $16.68 M | 17.52% | 1.43% |
| SATURN V CAPITAL MANAGEMENT LLC | 11/14/2024 | 874,590 | $15.81 M | 47.41% | 1.35% |
| PROPEL BIO MANAGEMENT, LLC | 11/13/2024 | 869,927 | $15.73 M | 0.00% | 1.35% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 862,918 | $15.60 M | 7.06% | 1.34% |
| ORACLE INVESTMENT MANAGEMENT INC | 11/14/2024 | 749,487 | $13.55 M | 233.11% | 1.16% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 728,490 | $13.17 M | -12.33% | 1.13% |
| SIMPLIFY ASSET MANAGEMENT INC. | 11/12/2024 | 521,935 | $9.44 M | 0.00% | 0.81% |
| SIREN, L.L.C. | 11/13/2024 | 460,753 | $8.33 B | 100.00% | 0.71% |
| EAGLE ASSET MANAGEMENT INC | 11/12/2024 | 455,196 | $7.67 M | 25.93% | 0.70% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 439,816 | $7.95 M | 100.00% | 0.68% |
| MORGAN STANLEY | 11/14/2024 | 439,490 | $7.95 M | -42.37% | 0.68% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 434,221 | $7.85 M | 4.06% | 0.67% |
| STEPSTONE GROUP LP | 11/12/2024 | 422,085 | $7.63 B | 0.00% | 0.65% |
| GHOST TREE CAPITAL, LLC | 11/14/2024 | 375,000 | $6.78 M | -37.50% | 0.58% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 292,860 | $5.29 M | 2.45% | 0.45% |
| WASATCH ADVISORS LP | 11/14/2024 | 246,942 | $4.46 M | 100.00% | 0.38% |
| CITADEL ADVISORS LLC | 11/14/2024 | 220,403 | $3.98 M | 179.64% | 0.34% |
| EAM INVESTORS, LLC | 11/13/2024 | 216,448 | $3.91 M | 100.00% | 0.33% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 208,640 | $3.77 M | 23.95% | 0.32% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 178,670 | $3.23 M | 100.00% | 0.28% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 173,383 | $3.13 M | -23.50% | 0.27% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 154,374 | $2.79 M | 9.47% | 0.24% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 154,030 | $2.78 M | -49.24% | 0.24% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 143,707 | $2.60 M | 100.00% | 0.22% |
| JPMORGAN CHASE & CO | 12/26/2024 | 135,431 | $2.45 M | 0.80% | 0.21% |
| MOORE CAPITAL MANAGEMENT, LP | 11/14/2024 | 130,000 | $2.35 M | 8.33% | 0.20% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 103,779 | $1.88 M | 5.86% | 0.16% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 98,191 | $1.78 M | -14.41% | 0.15% |
| STATE OF WISCONSIN INVESTMENT BOARD | 11/14/2024 | 81,770 | $1.48 M | -28.01% | 0.13% |
| SWISS NATIONAL BANK | 11/07/2024 | 73,300 | $1.33 M | 30.89% | 0.11% |
Phathom Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 149 institutional investors and hedge funds held shares of Phathom Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Frazier Life Sciences Management, L.P.: 10.11 M
Medicxi Ventures Management (Jersey) Ltd: 7.46 M
JENNISON ASSOCIATES LLC: 5.87 M
Invesco Ltd.: 4.1 M
Carlyle Group Inc.: 3.5 M
BlackRock Funding, Inc. /DE: 3.12 M
112.40% of Phathom Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 76.28 M shares in the last 24 months. This purchase volume represents approximately $623.98 M in transactions.